Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 853 in inadequately controlled asthma
NCT01018550Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Vidupiprant in asthma, sponsored by Amgen. Started Oct 2009; status: completed.
02
Drugs
Vidupiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01018550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018550.